Sean D. Sullivan, BScPharm, MSc, PhD, is Professor and Associate Dean for Research at the University of Washington School of Pharmacy. He holds a joint appointment as Professor of Health Services in the School of Public Health, is Director of the UW Pharmaceutical Outcomes Research and Policy Program (PORPP) and co-Director of the University of Washington Centers for Comparative and Health Systems Effectiveness (CHASE Alliance). He holds adjunct appointments in the School of Medicine, the Public Health Sciences Division at the Fred Hutchinson Cancer Research Center, and at Group Health Research Institute.
He completed his bachelor's degree in pharmacy from Oregon State University in 1983, master's degree in administrative and economic sciences from the University of Texas in 1986 and PhD in health economics and policy from the University of California-Berkeley in 1991.
Dr. Sullivan has authored more than 300 journal articles, book chapters, task force reports and organizational and governmental publications. In many of these writings, he has assessed the evidence and applications of medical technology in relation to coverage and reimbursement decisions. His research interests include technology assessment, medical decision-making and economic evaluation of medical technology. He is the past chair of the Academy of Managed Care Pharmacy executive committee on the AMCP Format for Formulary Submissions - the United States evidence-based guidelines for formulary decision-making.
Dr. Sullivan is a member of the Medicare Evidence Development and Coverage Advisory Committee. He is also on the editorial boards of Value in Health, PharmacoEconomics, European Journal of Health Economics and Core Evidence. He is a past president of the International Society for Pharmacoeconomics and Outcomes Research.
Technology assessment; medical decision making; economic evaluation of pharmaceuticals, particularly in the areas of respiratory disorders, organ transplantation, HIV/AIDS, mental health and clinical decision making
SciVal Experts Profile
office: H-375, Health Sciences Building
1959 NE Pacific Street
Seattle, WA 98195-7630
campus box: 357630
MS University of Texas (Austin), 1986 (Pharmacy)
BS Oregon State University, 1983 (Pharmacy)
- HSERV 584
Assessing Outcomes in Health and Medicine
Hansen RN, Nguyen HP, Sullivan SD. Bioequivalent antiepileptic drug switching and the risk of seizure-related events. Epilepsy Res. 2013 May 28. doi:pii: S0920-1211(13)00127-7. 10.1016/j.eplepsyres.2013.04.010. [Epub ahead of print] PMID: 23726541
Sims ST, Kubo J, Desai M, Bea J, Beasley JM, Manson JE, Allison M, Seguin RA, Chen Z, Michael YL, Sullivan SD, Beresford S, Stefanick ML. Changes in Physical Activity and Body Composition in Postmenopausal Women over Time. Med Sci Sports Exerc. 2013 Feb 22. [Epub ahead of print] PMID: 23439422 PMCID: PMC3715578
Coffin PO, Sullivan SD. Cost-effectiveness of distributing naloxone to heroin users for lay overdose reversal in Russian cities. J Med Econ. 2013 Aug;16(8):1051-60. doi: 10.3111/13696998.2013.811080. Epub 2013 Jun 19. PMID: 23730942
Batty AJ, Hansen RN, Bloudek LM, Varon SF, Hayward EJ, Pennington BW, Lipton RB, Sullivan SD. The cost effectiveness of onabotulinumtoxinA for the prophylaxis of headache in adults with chronic migraine in the UK. J Med Econ. 2013 May 7. [Epub ahead of print] PMID: 23647483
PI: Sullivan Dates: 10/1/2010 - 9/30/2013